Results per Page:
Cell death on a chip: new tools for a new era of cancer biology
From The Folch Lab, University of Washington Bioengineering Department and Cancer Basic Biology Program of the Cancer Consortium
Highlights of Fred Hutch science in 2018
A look back at notable advances in immunotherapy, precision screening and more
Study finds that microinjection platform enables assessment of multiple cancer drugs directly in tumors, predicts systemic response
Data published in Science Translational Medicine show positive findings using patented new technology with multiple cancer drugs tested in xenografted mouse models and canine patients > Results from first-in-human study in lymphoma patients confirm feasibility for toxicity-sparing assessment of drug efficacy in cancer patients